Symbicort was first FDA-approved in 2006 as ... a long-acting beta2-agonist bronchodilator with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously disagrees ...
Cipla announced that it filed two generic respiratory drug applications with the US FDA in the last quarter, including a generic version of Symbicort and one other undisclosed inhalation product.